BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20954326)

  • 1. [Development of anti-inflammatory drugs targeted against prostaglandin-related molecules].
    Sato T; Nakajima T; Yamano Y
    Nihon Rinsho; 2010 Oct; 68(10):1835-9. PubMed ID: 20954326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
    Timmers L; Pasterkamp G; de Kleijn DP
    Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.
    Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T
    Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
    Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
    J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.
    Larsson K; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():161-5. PubMed ID: 26100239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
    Jachak SM
    Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advances of prostaglandin E
    Liu M; Guo MN; Chen LH
    Sheng Li Xue Bao; 2021 Aug; 73(4):665-680. PubMed ID: 34405222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases.
    Park JY; Pillinger MH; Abramson SB
    Clin Immunol; 2006 Jun; 119(3):229-40. PubMed ID: 16540375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
    Wang M; Song WL; Cheng Y; Fitzgerald GA
    J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.
    Xu S; Rouzer CA; Marnett LJ
    IUBMB Life; 2014 Dec; 66(12):803-11. PubMed ID: 25537198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis.
    Kudo I; Murakami M
    J Biochem Mol Biol; 2005 Nov; 38(6):633-8. PubMed ID: 16336776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
    Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
    Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.
    Bahia MS; Katare YK; Silakari O; Vyas B; Silakari P
    Med Res Rev; 2014 Jul; 34(4):825-55. PubMed ID: 25019142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.